ALV vs TXRH

Autoliv (ALV) shows mixed financial health with a weak Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score to assess distress risk. The stock appears reasonably valued with a P/E of 13.03 below sector average, strong ROE of 31.01%, and solid earnings growth of 31% YoY, but faces concerns around liquidity (Current Ratio: 0.95) and technical weakness (Technical Trend: 10/100). Dividend strength is moderate at 50/100 with a sustainable 2.48% yield, while analyst consensus leans positive with a $138.72 target price. However, insider sentiment is lukewarm and recent price performance shows decelerating momentum despite solid long-term returns.

TXRH exhibits a concerning divergence between its current market price ($161.05) and its deterministic value, with a Piotroski F-Score of 4/9 indicating only stable to weak financial health. The stock trades at a massive premium to both its Graham Number ($55.14) and Intrinsic Value ($42.70), while fundamental growth has stalled with earnings plummeting -25.9% YoY. This valuation gap is exacerbated by a streak of four consecutive earnings misses and bearish insider activity, suggesting the current price is unsupported by underlying financial performance.